Document Detail


Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).
MedLine Citation:
PMID:  10334434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome. BACKGROUND: Complete angioplasty revascularization (CR) is often not planned nor attempted in patients with multivessel coronary disease, and the extent to which this influences outcome is unclear. METHODS: Before randomization, in the Bypass Angioplasty Revascularization Investigation, all angiograms were assessed for intended CR or IR via angioplasty. Outcomes were compared among patients with IR intended if assigned to angioplasty, randomized to coronary artery bypass graft surgery (CABG) versus angioplasty; and within angioplasty patients only, among patients with IR versus CR intended. RESULTS: At 5 years, there was a trend for higher overall (88.6% vs. 84.0%) and cardiac survival (94.5% vs. 92.1%) in CABG versus angioplasty patients with IR intended. The excess mortality in angioplasty patients occurred solely in diabetic subjects; overall and cardiac survival were similar among nondiabetic CABG and angioplasty patients. Freedom from myocardial infarction (MI) at 5 years was higher in nondiabetic CABG versus angioplasty patients (92.4% vs. 85.2%, p = 0.02), vet was similar to the rate observed (85%) in nondiabetic CABG and angioplasty patients with CR intended. Five-year rates of death, cardiac death, repeat revascularization and angina were similar in all angioplasty patients with IR versus CR intended. However, a trend for greater freedom from subsequent CABG was seen in CR patients (70.3% vs. 64.0%, p = 0.08). CONCLUSIONS: Intended incomplete angioplasty revascularization in nondiabetic patients with multivessel disease who are candidates for both angioplasty and CABG does not compromise long-term survival; however, subsequent need for CABG may be increased with this strategy. Whether the risk of long-term MI is also increased remains uncertain.
Authors:
M G Bourassa; K E Kip; A K Jacobs; R H Jones; G Sopko; A D Rosen; B L Sharaf; L Schwartz; B R Chaitman; E L Alderman; D R Holmes; G S Roubin; K M Detre; R L Frye
Related Documents :
2317854 - "high-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic...
8837564 - Initial cost of primary angioplasty for acute myocardial infarction.
3155894 - Assessment of hemodynamic significance of isolated stenoses of the left anterior descen...
9758574 - Employment after coronary angioplasty or coronary bypass surgery in patients employed a...
6657654 - Myocardial perfusion and left ventricular performance during long and short haemodialys...
11843514 - Mitral valve repair for degenerative disease.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  33     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-06-03     Completed Date:  1999-06-03     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1627-36     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Montreal Heart Institute, Canada. bourassa@icm.umontreal.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angioplasty, Transluminal, Percutaneous Coronary*
Canada
Coronary Angiography
Coronary Artery Bypass*
Coronary Disease / mortality,  radiography,  therapy*
Diabetic Angiopathies / mortality,  radiography,  therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
Outcome and Process Assessment (Health Care)
Recurrence
Survival Rate
United States
Grant Support
ID/Acronym/Agency:
HL38493/HL/NHLBI NIH HHS; HL38504/HL/NHLBI NIH HHS; HL38509/HL/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. C...
Next Document:  Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves.